InflaRx IFRX
NASDAQ IFRX
$2.05 -0.04 (-1.91%)
As of: Sep 10, 2026 · 3:59 PM EDT

InflaRx (IFRX) Other Non-Current Assets (2016 - 2026)

InflaRx's (IFRX) quarterly Other Non-Current Assets came in at $146691.2 in Q2 2026, down 27.08% year-over-year from $201167.3 in Q2 2025, and down 9.98% quarter-over-quarter from $162958.4 in Q1 2026.

Analysis

InflaRx (IFRX) Other Non-Current Assets (2016 - 2026) Analysis & Trends

InflaRx has disclosed Other Non-Current Assets across 11 years of filings, most recently posting $146691.2 for Q2 2026.

  • In Q2 2026, Other Non-Current Assets fell 27.08% year-over-year to $146691.2; the TTM figure through Jun 2026 stood at $146691.2 (down 27.08% YoY), while the FY2025 annual figure was $170825.2, down 21.73% from the prior year.
  • Other Non-Current Assets came in at $146691.2 for Q2 2026 at InflaRx, down from $162958.4 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $372098.7 in Q1 2022 to a low of $146691.2 in Q2 2026.
  • Average Other Non-Current Assets over 5 years is $258566.6, with a median of $256786.9 recorded in 2024.
  • Year-over-year, Other Non-Current Assets declined 11.71% in 2022 and fell 27.08% in 2026.
  • Over 5 years, Other Non-Current Assets stood at $314303.5 in 2022, then slipped by 11.93% to $276803.8 in 2023, then decreased by 21.16% to $218242.4 in 2024, then retreated by 19.36% to $176001.1 in 2025, then slipped by 16.65% to $146691.2 in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $146691.2 in Q2 2026, $162958.4 in Q1 2026, and $176001.1 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 12.98 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 4.75 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 2.31 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 124.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 618.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 65.13 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 831.80 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 29.59 Mn
10 InflaRx 139.29 Mn -44.96 Mn 2.74 Mn 146,691.23
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 146,691.23
Mar 31, 2026 162,958.43
Dec 31, 2025 176,001.05
Sep 30, 2025 192,259.29
Jun 30, 2025 201,167.35
Mar 31, 2025 200,882.58
Dec 31, 2024 218,242.44
Sep 30, 2024 238,852.86
Jun 30, 2024 248,491.81
Mar 31, 2024 265,082.05
Dec 31, 2023 276,803.83
Sep 30, 2023 294,492.03
Jun 30, 2023 309,019.32
Mar 31, 2023 318,805.06
Dec 31, 2022 314,303.52
Sep 30, 2022 353,470.73
Jun 30, 2022 364,576.99
Mar 31, 2022 372,098.72
Dec 31, 2021 385,021.73
Sep 30, 2021 401,632.24